Efficacy of 0.05% Cyclosporine A Ophthalmic Emulsion for Pre-existing Dry Eye Disease in Patients Undergoing Pars Plana Vitrectomy: A Randomised Controlled Trial
Ophthalmology and Therapy · 16.11.2026
DOI: 10.1007/s40123-026-01536-5 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Ophthalmology and Therapy, online erschienen am 16.11.2026. Verfasst von Yanan Shen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, China. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Bethune Charitable Foundation.
Abstract (Originalsprache)
Introduction
Evaluation of the efficacy of adjunctive topical 0.05% cyclosporine A (CsA) in patients with pre-existing dry eye disease (DED) undergoing pars plana vitrectomy (PPV).
Methods
This prospective, single‑centre, two-arm randomised controlled trial enrolled 163 adults with pre‑existing DED undergoing PPV. Participants received either 0.05% CsA plus 0.1% sodium hyaluronate or 0.1% sodium hyaluronate alone for 3 months. The primary outcome was the change in Ocular Surface Disease Index (OSDI) score from baseline to 3 months. Secondary outcomes included non‑invasive tear break‑up time (NIBUT), Schirmer I test (SIT), tear meniscus height (TMH) and corneal fluorescein staining (CFS). OSDI, NIBUT, SIT and TMH were analysed using adjusted linear mixed‑effects models, while CFS was analysed using a binomial logistic generalised linear mixed-effects model.
Results
All 163 randomised participants (CsA, n = 82; control, n = 81) were included in the longitudinal analyses of ocular surface outcomes using all available repeated measurements. The adjusted between-group difference in OSDI change from baseline to 3 months was −5.29 points (95% confidence interval (CI), −6.53 to −4.05; P < 0.001). A complete-case sensitivity analysis yielded consistent results (−5.19 points; 95% CI, −6.45 to −3.93; P < 0.001). A significant group-by-time interaction was observed for OSDI ( P < 0.001). Exploratory analyses of secondary outcomes also showed significant group-by-time interactions for NIBUT ( P = 0.002), SIT ( P = 0.040), TMH ( P < 0.001) and CFS ( P = 0.009).
Conclusions
In patients with pre-existing DED undergoing PPV, adjunctive topical 0.05% CsA was associated with modest OSDI improvement and more favourable changes in several objective ocular surface outcomes. Further confirmation in larger, double-masked trials is warranted. Trial Registration Chinese Clinical Trial Registry identifier, ChiCTR2600129992.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, China.
- Future Medical Laboratory, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, China.
- Department of Ophthalmology, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, China. eyejiangbo@126.com.
- Department of Ophthalmology, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, China. sundawei@hrbmu.edu.cn.
Förderung
- Bethune Charitable Foundation
Zitieren
APA
Shen, Y., Lu, H., Zhu, J., Peng, Y., Zhang, Y., Zhang, X., Hu, Q., Zhang, B., Jiang, B., & Sun, D. (2026). Efficacy of 0.05% Cyclosporine A Ophthalmic Emulsion for Pre-existing Dry Eye Disease in Patients Undergoing Pars Plana Vitrectomy: A Randomised Controlled Trial. Ophthalmology and Therapy. https://doi.org/10.1007/s40123-026-01536-5
Vancouver
Shen Y, Lu H, Zhu J, Peng Y, Zhang Y, Zhang X, et al. Efficacy of 0.05% Cyclosporine A Ophthalmic Emulsion for Pre-existing Dry Eye Disease in Patients Undergoing Pars Plana Vitrectomy: A Randomised Controlled Trial. Ophthalmology and Therapy. 2026. doi:10.1007/s40123-026-01536-5
BibTeX
@article{Shen2026,
author = {Shen, Yanan and Lu, Haomin and Zhu, Jiajing and Peng, Yi and Zhang, Yuege and Zhang, Xingguo and Hu, Qiang and Zhang, Boyu and Jiang, Bo and Sun, Dawei},
title = {Efficacy of 0.05% Cyclosporine A Ophthalmic Emulsion for Pre-existing Dry Eye Disease in Patients Undergoing Pars Plana Vitrectomy: A Randomised Controlled Trial},
journal = {Ophthalmology and Therapy},
year = {2026},
doi = {10.1007/s40123-026-01536-5}
}
EUVIMED